Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

How the pandemic shifted Roche’s priorities and R&D investments

How the pandemic shifted Roche’s priorities and R&D investments

FromConversations in Healthcare


How the pandemic shifted Roche’s priorities and R&D investments

FromConversations in Healthcare

ratings:
Length:
31 minutes
Released:
Nov 15, 2021
Format:
Podcast episode

Description

In this episode of Conversations in Healthcare, Mike Ward speaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Richard shares how the pandemic has shifted Roche’s priorities and why the organization has heavily increased their investment in R&D. Learn more in the full episode.  Hosted on Acast. See acast.com/privacy for more information.
Released:
Nov 15, 2021
Format:
Podcast episode

Titles in the series (48)

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.   Hosted on Acast. See acast.com/privacy for more information.